Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rossari BiotechNSE:ROSSARI -0.85%85 3-Year EBITDA Growth Rate is 10.50% as of Jun. 2026, which is 54% below its 10-year median of 22.85. GuruFocus rates NSE:ROSSARI with a GF Score™ of 85/100 and a GF Value™ of ₹926.04 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,412 Chemicals companies, Rossari Biotech ranks better than 68.48% on this metric.
During the past 12 months, Rossari Biotech's average EBITDA Per Share Growth Rate was 18.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 10.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 15.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Rossari Biotech was 41.20% per year. The lowest was 10.50% per year. And the median was 22.85% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Rossari Biotech 3-Year EBITDA Growth Rate Related Terms
NSE:ROSSARI vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 10.50% mean?
Rossari Biotech (NSE:ROSSARI) has a 3-Year EBITDA Growth Rate of 10.50% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Rossari Biotech and its competitors. This is 54% below median its historical median of 22.85. Over the past decade, Rossari Biotech's 3-Year EBITDA Growth Rate has ranged from 10.50 to 41.20. According to the industry distribution chart, Rossari Biotech ranks #445 out of 1412 companies in the Chemicals industry, placing it in the top 31.5%.
Is Rossari Biotech's 3-Year EBITDA Growth Rate too high?
Rossari Biotech's current 3-Year EBITDA Growth Rate of 10.50% is 54% below median its 10-year median of 22.85. Over the past 10 years, this metric has ranged from a low of 10.50 to a high of 41.20. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.70. Rossari Biotech's value of 10.50% is 1400% above this industry median. Based on the distribution chart, Rossari Biotech ranks #445 out of 1412 companies in the Chemicals industry, which is above the industry midpoint. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #445 out of 1412 companies for 3-Year EBITDA Growth Rate. This puts Rossari Biotech in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.70. Rossari Biotech's value of 10.50% is 1400% above this benchmark. Historically, Rossari Biotech's own 3-Year EBITDA Growth Rate has ranged from 10.50 to 41.20 over the past decade. While the company's 10-year median is 22.85 vs. the industry median of 0.70, Rossari Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.70, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current 3-Year EBITDA Growth Rate of 10.50% is 1400% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Rossari Biotech and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current 3-Year EBITDA Growth Rate is 10.50%, which is 54% below median its own 10-year median of 22.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹926.04, compared to a current price of ₹454.60 — trading 50.9% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 10.50%, which is 54% below median its 10-year median of 22.85 and 1400% above the Chemicals industry median of 0.70. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current 3-Year EBITDA Growth Rate is 10.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹454.60 is trading 50.9% below its estimated GF Value™ of ₹926.04.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
3-Year EBITDA Growth Rate: 10.50% (54% below median its 10-year median of 22.85)
GF Value™: ₹926.04 vs. price of ₹454.60 (50.9% below fair value)
Industry Position: 1400% above the Chemicals median (#445 of 1412)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score
Get the complete analysis for NSE:ROSSARI
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
